Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-006893
Filing Date
2017-02-01
Accepted
2017-02-01 20:59:46
Documents
1
Period of Report
2017-01-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4138
  Complete submission text file 0001209191-17-006893.txt   5456
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Issuer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XENCOR, INC. 111 WEST LEMON AVENUE MONROVIA CA 91016
Business Address
Dahiyat Bassil I (Reporting) CIK: 0001591312 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36182 | Film No.: 17566507